Health Care Equipment

Autonomix Medical

Autonomix Medical released FY2026 Semi-Annual Earnings on November 12, 2025 (EST), actual revenue USD 0, actual EPS USD -2.5286

Autonomix Medical released FY2026 Q2 earnings on November 12, 2025 (EST), with actual revenue of USD 0 (forecast USD 0) and actual EPS of USD -1.3768 (forecast USD -1.5)

Autonomix Medical released FY2026 Q1 earnings on August 13, 2025 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -1.0746 (forecast USD -0.98)

Autonomix Medical Inc Secures New US Patent

Autonomix Medical Expands Clinical Research for Visceral Cancer Pain with Ethics Committee Approval

Autonomix Medical released FY2025 Q4 earnings on May 29 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -1.1596 (forecast USD -1.235)

Autonomix Medical released FY2025 earnings on May 29 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -6.4593 (forecast USD -3.955)

Autonomix Medical Releases Annual Financial Report

Autonomix Obtains New Patent

Autonomix's Pain Treatment Trial Significantly Reduces Pain Levels

Autonomix Medical Reports Positive Results in Pancreatic Cancer Pain Management Trial

Autonomix Medical released FY2025 Q3 earnings on February 13, 2025 (EST), with actual revenue of 0 USD and EPS of -1.4644 USD (forecast EPS was -2.4 USD)

Autonomix Medical released FY2025 9 Months Earnings on February 13 (EST) with actual revenue of 0 USD and EPS of -6.7879 USD

Autonomix Medical Announces CEO Corner Program Discussing Insights from J.P. Morgan Healthcare Conference

Autonomix Medical released FY2025 Semi-Annual earnings on November 8, 2024 (EST) with actual revenue of USD 0 and EPS of USD -4.4768

Autonomix Medical released FY2025 Q2 earnings on November 8, 2024 (EST) with actual EPS of USD -2.2741

Autonomix Medical, Inc. (NASDAQ: AMIX) announces positive results from human clinical trial for pancreatic cancer pain treatment

Autonomix Medical released FY2025 Q1 earnings on August 13 (EST) with actual revenue of USD 0 and EPS of USD -2.2025

Autonomix Medical released FY2024 Annual Earnings on May 31 (EST), actual revenue USD 0, actual EPS USD -14.8224

Autonomix Medical released FY2024 Q4 earnings on May 31 (EST) with actual revenue of USD 0 and EPS of USD -4.6489

AdvisorShares MSOS 2x Daily ETF

cbdMD

Tryhard

Roundhill Cannabis ETF

Neo-Concept

Amplify Seymour Cannabis ETF

AdvisorShares Pure US Cannabis ETF

Canopy Growth

RYTHM

Tilray Brands

Please note that a "Suspected value trap" is a stock that appears The stock looks financially sound and severely undervalued, but behind the low valuation is a long-term decline in business capacity or a serious financial crisis, or even the risk of bankruptcy in the short term.

Suspected value trap